These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12629654)

  • 41. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
    Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
    Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
    Kis LL; Nagy N; Klein G; Klein E
    Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
    Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
    Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity.
    Henning G; Kraft MS; Derfuss T; Pirzer R; de Saint-Basile G; Aversa G; Fleckenstein B; Meinl E
    Eur J Immunol; 2001 Sep; 31(9):2741-50. PubMed ID: 11536173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.
    Lappalainen I; Giliani S; Franceschini R; Bonnefoy JY; Duckett C; Notarangelo LD; Vihinen M
    Biochem Biophys Res Commun; 2000 Mar; 269(1):124-30. PubMed ID: 10694488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors.
    Tovar V; del Valle J; Zapater N; Martin M; Romero X; Pizcueta P; Bosch J; Terhorst C; Engel P
    Immunogenetics; 2002 Sep; 54(6):394-402. PubMed ID: 12242590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.
    Ma CS; Nichols KE; Tangye SG
    Annu Rev Immunol; 2007; 25():337-79. PubMed ID: 17201683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis.
    Takei M; Ishiwata T; Mitamura K; Fujiwara S; Sasaki K; Nishi T; Kuga T; Ookubo T; Horie T; Ryu J; Ohi H; Sawada S
    Int Immunol; 2001 Apr; 13(4):559-65. PubMed ID: 11282995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between SAP and FynT: Inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor.
    Chen R; Latour S; Shi X; Veillette A
    Mol Cell Biol; 2006 Aug; 26(15):5559-68. PubMed ID: 16847311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance and mechanism of 'switch' function of SAP family adapters.
    Veillette A; Dong Z; Pérez-Quintero LA; Zhong MC; Cruz-Munoz ME
    Immunol Rev; 2009 Nov; 232(1):229-39. PubMed ID: 19909367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SAP and SLAM expression in anti-CD3 activated lymphocytes correlates with cytotoxic activity.
    Mehrle S; Frank S; Schmidt J; Schmidt-Wolf IG; Märten A
    Immunol Cell Biol; 2005 Feb; 83(1):33-9. PubMed ID: 15661039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fine-tuning of immune responses by SLAM-related receptors.
    Bhat R; Eissmann P; Endt J; Hoffmann S; Watzl C
    J Leukoc Biol; 2006 Mar; 79(3):417-24. PubMed ID: 16365151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. X-linked lymphoproliferative disease: genetics and biochemistry.
    Nichols KE
    Rev Immunogenet; 2000; 2(2):256-66. PubMed ID: 11258422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maternal onset de novo SH2D1A mutation and lymphocytic choriomeningitis virus infection in a patient with X‑linked lymphoproliferative disease type 1: a case report.
    Liu J; Tian W; Wang F; Teng W; Zhang Y; Tong C; Zhang C; Ju Y; Zhang B; Zhao S; Liu H
    Mol Med Rep; 2015 May; 11(5):3291-4. PubMed ID: 25572984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.
    Palendira U; Low C; Bell AI; Ma CS; Abbott RJ; Phan TG; Riminton DS; Choo S; Smart JM; Lougaris V; Giliani S; Buckley RH; Grimbacher B; Alvaro F; Klion AD; Nichols KE; Adelstein S; Rickinson AB; Tangye SG
    J Exp Med; 2012 May; 209(5):913-24. PubMed ID: 22493517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.
    Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W
    Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLAM family receptors and SAP adaptors in immunity.
    Cannons JL; Tangye SG; Schwartzberg PL
    Annu Rev Immunol; 2011; 29():665-705. PubMed ID: 21219180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
    Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
    Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
    Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
    J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.
    Simarro M; Lanyi A; Howie D; Poy F; Bruggeman J; Choi M; Sumegi J; Eck MJ; Terhorst C
    Int Immunol; 2004 May; 16(5):727-36. PubMed ID: 15096483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.